{
    "Clinical Trial ID": "NCT00293540",
    "Intervention": [
        "INTERVENTION 1: ",
        "  A Mid-luteal Surgery",
        "[Not Specified]",
        "INTERVENTION 2: ",
        "  B Mid-follicular Surgery",
        "[Not Specified]"
    ],
    "Eligibility": [
        "Inclusion Criteria:",
        "  Estrogen receptor or progesterone receptor positive breast cancer",
        "  Premenopausal with regular menstrual cycles",
        "Exclusion Criteria:",
        "  Current oral contraceptives"
    ],
    "Results": [
        "Outcome Measurement: ",
        "  Overall Survival",
        "  Assess whether patients who undergo surgical oophorectomy in the history-estimated mid-luteal phase of their menstrual cycles survive longer than patients who undergo this surgery in the history-estimated mid-follicular phase of their menstrual cycles.",
        "  Time frame: Up to 9 years",
        "Results 1: ",
        "  Arm/Group Title: A Mid-luteal Surgery",
        "  Arm/Group Description: [Not Specified]",
        "  Overall Number of Participants Analyzed: 115",
        "  Median (95% Confidence Interval)",
        "  Unit of Measure: years  2.14        (1.53 to 2.67)",
        "Results 2: ",
        "  Arm/Group Title: B Mid-follicular Surgery",
        "  Arm/Group Description: [Not Specified]",
        "  Overall Number of Participants Analyzed: 119",
        "  Median (95% Confidence Interval)",
        "  Unit of Measure: years  2.00        (1.61 to 2.31)"
    ],
    "Adverse Events": [
        "Adverse Events 1:",
        "  Total: 0/115 (0.00%)",
        "  Deep vein thrombosis * [1]0/115 (0.00%)",
        "Adverse Events 2:",
        "  Total: 1/119 (0.84%)",
        "  Deep vein thrombosis * [1]1/119 (0.84%)"
    ]
}